2018
DOI: 10.1097/crd.0000000000000190
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock

Abstract: Myocardial infarction (MI) complicated by cardiogenic shock (MI-CS) is a major cause of cardiovascular morbidity and mortality. Predictors of outcomes in MI-CS include clinical, laboratory, radiologic variables, and management strategies. This article reviews the existing literature on short- and long-term predictors and risk stratification in MI complicated by CS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

7
53
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(62 citation statements)
references
References 162 publications
7
53
2
Order By: Relevance
“…These findings are in line with previous reports which showed that CS patients represent a high-risk group for the development of MA (Gorenek et al, 2015). Moreover, a reduced EF and the occurrence of MA are known risk factors for mortality in patients after myocardial infarction (Askari et al, 2009;Acharya, 2018). All included patients were admitted to the ICU with clinical signs of end-organ hypoperfusion, low CI, and the need of catecholamines for circulatory support.…”
Section: Discussionsupporting
confidence: 88%
“…These findings are in line with previous reports which showed that CS patients represent a high-risk group for the development of MA (Gorenek et al, 2015). Moreover, a reduced EF and the occurrence of MA are known risk factors for mortality in patients after myocardial infarction (Askari et al, 2009;Acharya, 2018). All included patients were admitted to the ICU with clinical signs of end-organ hypoperfusion, low CI, and the need of catecholamines for circulatory support.…”
Section: Discussionsupporting
confidence: 88%
“…However, the severity of CS after AMI and clinical outcome vary greatly [1][2][3][4][5][6]. Whilst patients over 75 years of age are at highest risk of CS and death [7,9], this cohort may still benefi t from aggressive management when appropriate [9].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, 80% of the deaths due to AMI occurs in those over 65 years of age and 60% of the mortality in this cohort occurs in those over 75 years old [8]. Increasing age is associated with higher risk of developing CS after AMI [7,9]. Although elderly patients are at higher risk, they may still benefi t from aggressive treatment of CS [9].…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…Although there have been great improvements in pharmacological treatment and reperfusion therapy of patients with CS in the last two decades, the mortality rate among these patients still remains to be high (16). Additionally, this condition is frequently complicated with the deterioration of renal functions that has been related with further increase in mortality rates (17,18). Hence, adequate intravenous hydration, timely start of continuous renal replacement therapy, and mechanical circulatory support would be crucial steps after identification of these patients.…”
Section: Discussionmentioning
confidence: 99%